Drug Trial Radar · NCT03392376
Agents Intervening Against Delirium in Intensive Care Unit
Last checked: Nov 20, 2026Latest source record: Jan 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,000
Planned (sponsor's estimate)
Start
Jun 13, 2018
Primary completion
Jul 9, 2022
Study completion Jul 2023
Sponsor
- Lead sponsor
- Zealand University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Centre for Research in Intensive Care (CRIC); Copenhagen Trial Unit, Center for Clinical Intervention Research; Scandinavian Critical Care Trials Group; The Danish Centre of Applied Social Science (VIVE)
- First posted
- Jan 8, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Delirium is a frequent condition in the Intensive Care Unit (ICU) with no existing evidence-based treatment. The aim of the AID-ICU study is to assess the benefits and harms of haloperidol treatment for the management of ICU acquired delirium.
Conditions
- Delirium
Interventions
Haloperidol InjectionDrug
ICU patients with diagnosed delirium are treated with 2,5mg haloperidol x 3 daily intravenously with additional as needed doses to a maximum of 20mg/daily.
Saline (0,9%)Other
ICU patients with diagnosed delirium are treated with 0,5ml isotonic saline x 3 daily and as needed doses to a maximum of 4ml/daily, corresponding to the algorithm in the experimental arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Days alive out of the hospital within 90 days post-randomizationTime frame: 90 days
- 90-day mortalityTime frame: 90 days
- Hospital Length of StayTime frame: 90 days
Locations
16 sites in 4 countries. Site status is shown where the registry gives one.
Dept. Intensive Care, Aabenraa Hospital
Aabenraa, Denmark
Dept. of Intensive Care, Aalborg University Hospital
Aalborg, Denmark
Dept. of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Dept. of Intensive Care, Herlev Hospital
Herlev, Denmark
Dept. of Intensive Care, Herning Hospital
Herning, Denmark
Dept. of Intensive Care, Nordsjaelland Hospital
Hillerød, Denmark
Regionshospitalet Nordjylland, Hjørring
Hjørring, Denmark
Dept. of Intensive Care, Holstebro Hospital
Holstebro, Denmark
Dept. of Intensive Care, Zealand University Hospital, Køge
Køge, Denmark
Dept. of Intensive Care, Nykøbing Falster Hospital
Nykøbing Falster, Denmark
Dept of intensive care, Odense University Hospital
Odense, Denmark
Dept. of Intensive Care, Zealand University Hospital Roskilde
Roskilde, Denmark
Dept. of Intensive Care, Sønderborg Hospital
Sønderborg, Denmark
Dept. of Intensive Care, Helsinki University Central Hospital
Helsinki, Finland
Dept. of Neurosurgical Intensive Care, San Gerardo Hospital, Monza.
Monza, Italy
UHW Adult Critical Care Cardiff
Cardiff, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.